Learning versus confirming in clinical drug development*
Lewis B. Sheiner · Clinical Pharmacology & Therapeutics · 1997
Cited by 631 works. doi:10.1016/s0009-9236(97)90160-0
Authors
References
- Intention-to-treat analysis and the goals of clinical trials*
- Practical Implications of Modes of Statistical Inference for Causal Effects and the Critical Role of the Assignment Mechanism
- Use and Abuse of Regression
- Practical Implications of Modes of Statistical Inference for Causal Effects and the Critical Role of the Assignment Mechanism
- Mixed-Effects Nonlinear Regression for Unbalanced Repeated Measures
- Pharmacologically Guided Phase I Clinical Trials Based Upon Preclinical Drug Development
- Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand
- Applying Bayesian ideas in drug development and clinical trials
- A simulation study comparing designs for dose ranging
- Population approaches in drug development